We noticed you are on our AU page. Want to switch regions? Choose from the options:

Alt
/content/dam/asset-migration/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Prof Michael Chao.jpg

Prof Michael Chao

Prof Michael Chao
MBBS (Hons) FRANZCR AFRACMA DMedSc, Radiation Oncologist

Languages spoken

English, Cantonese

Expert in

Breast, Lung, Urology, Stereotactic Radiation Therapy, Brachytherapy and Rectal Spacers

Overview

Centres

Ringwood (Oncology)
Ringwood (Oncology)

Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135

-37.81110647223415, 145.24382831349104
/au/our-centres/ringwood-oncology
Frankston (Oncology)
Frankston (Oncology)

Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199

-38.154231317922665, 145.13303741347642
/au/our-centres/frankston

Specialises in

Breast cancer
Condition
Condition/Cancer
Condition/Cancer/Breast Cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung Cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate Cancer

Treatments

Brachytherapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Brachytherapy
DCISionRT®
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/DCISionRT
Prostate cancer spacers
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Prostate Cancer Spacers
Radiation therapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Radiation Therapy
Stereotactic ablative/body radiation therapy (SABR/SBRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Stereotactic ablative radiation therapy (SABR)

Special clinical interests in Breast, Lung, Urology, Stereotactic Radiation Therapy, Brachytherapy and Rectal Spacers

Michael is a Professor of Radiation Oncology specialising in breast, lung and prostate cancers.

He has over 22 years of experience as a radiation oncologist. His particular area of expertise is in prostate brachytherapy (which includes both Iodine-125 low dose rate (LDR) permanent seed implants and Iridium-192 high dose rate (HDR) temporary implants) and rectal spacers for prostate cancer which he introduced in 2013. He has now completed more than 1000 prostate cancer implants and more than 800 rectal spacer procedures. In addition, he has a major interest in the use of preoperative radiotherapy for locally advanced breast cancers prior to breast reconstructions and also for early disease where he is leading innovative partial breast treatments.

Michael completed his MBBS at Monash University in 1991 graduating with Honours. He received his Fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 1999. This was followed by two years as a research fellow at the DNA Research Laboratory at the Peter MacCallum Cancer Centre. He was both an NHMRC Scholar and Sir Edward ‘Weary’ Dunlop Research Fellow. He has also completed his doctorate (DMedSc) with the University of Melbourne.

He has a strong commitment to research with more than 90 publications and supervises a number of PhD and MPhil students. He commenced as a consultant radiation oncologist in 2000 joining Genesis Care Victoria. He consults at the Ringwood and Frankston Genesis Care Radiation Oncology Centres. He is both an honorary radiation oncologist at Maroondah Hospital (Eastern Health) and VMO at the Olivia Newton John Cancer and Wellness Centre where he is the breast cancer lead.

Awards

  • Jean C Tolhurst
  • NHMRC Scholar

Research interests

  • Preoperative breast RT for facilitation of one stage mastectomy and breast reconstruction

 

  • Rectal spacing for prostate radiation therapy
  • Stereotactic prostate radiation therapy

Professional memberships

  • American Society of Therapeutic Radiology & Oncology
  • European Society of Radiation Oncology
  • Australasian Society of Breast Diseases
  • American Brachytherapy Society
  • Australasian Brachytherapy Group

Publications

  • Quality of life after breast conserving therapy and adjuvant radiotherapy for non low risk ductal carcinoma insitu (BIG3-07/TROG 07.01): 2 year results of a randomised controlled phase 3 trial. King M, Link E, Whelan T, Olivotto I, Kunkler I, Westenberg A, Gruber G, Schofield P, Chua BH and BIG 3-07/TROG 07.01 trial investigators. Lancet Oncol. 2020; 21(5): 685-698.
  • Vertebral fractures following stereotactic body radiotherapy for spine metastases. Abbouchie H, Chao M, Tacey M, Wasiak J, Lim Joon D, Ho H, Guerrieri M, Ng M, Foroudi F. J Med Imaging Radiat Oncol. 2020; 64(2): 293-302.
  • Vertebral fractures following stereotactic body radiotherapy for spine oligometastasis: a multi-institutional analysis of patient outcomes. Abbouchie H, Chao M, Tacey M, Wasiak J, Lim Joon D, Ho H, Guerrieri M, Ng M, Foroudi F. Clin Oncol. 2020; 32(7): 433-441.
  • Assessment of intrafraction motion of the urinary bladder using magnetic resonance imaging (cineMRI). Wilson C, Moseshvili E, Tacey M, Quin I, Lawrentschuk N, Bolton D, Lim Joon D, Chao M, Dunshea T, Kron T, Foroudi F. Clin Oncol. 2020; 32(2): 101-109.
  • PSMA PET/CT guided stereotactic ablative body radiotherapy (SABR) for recurrent oligometastatic prostate cancer. Ong WL, Lim Joon D, Chao M, Farrugia B, Khoo V, Lawrentschuk N, Bolton D, Foroudi F. BJU Int. 2019; 124(S1): 19-30.